Back

Guideline-directed medical therapy and outcomes in frail patients with HFrEF and low blood pressure : insights from the JROADHF-NEXT

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Renal vulnerability: handle with care Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sakura Nagumo

Showa University Fujigaoka Hospital, Yokohama (Japan)

6 More presentations in this session

Presentation thumbnail
Impact of renin-angiotensin system inhibitors in patients with heart failure with reduced ejection fraction and advanced chronic kidney disease
Doctor Y. Tamaki (Tenri, JP)
Abstract Slides Video
Presentation thumbnail
Post-decongestion right heart catheterization is associated with GDMT optimization and improved outcomes in patients hospitalized for acute heart failure
Doctor K. Ishimaru (Iizuka, JP)
Abstract Slides Video
Presentation thumbnail
Bridging the vulnerable post-discharge window in acute heart failure: short and long term outcomes of a dedicated ambulatory advanced therapy center— a propensity score matched study
Doctor A. Abbo (Haifa, IL)
Abstract Slides Video
Presentation thumbnail
Preemptive cardiorenal phenotyping to forecast diuretic resistance in acute heart failure: derivation and internal validation of the RAPID-HF sequential hybrid model
Professor H. Al Farhan (Baghdad, IQ)
Abstract Slides Video
Presentation thumbnail
Treatment gradients across the left ventricular ejection fraction spectrum in ambulatory and acute heart failure: a multinational registry analysis
Doctor V. Rossel Mariangel (Santiago, CL)
Abstract Slides Video

Access the full session

Session thumbnail
Renal vulnerability: handle with care

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Optimising guideline-directed medical therapy in the sickest patients: how far can we go?
9 May 2026
thumbnail
Congress Presentation
Efficacy of sodium–glucose cotransporter 2 inhibitors in heart failure patients with low body mass index
28 August 2026
thumbnail
Congress Presentation
Longitudinal trajectories of guideline-directed medical therapy and 12-month mortality in acute heart failure: insights from the KorHF-III Registry
28 August 2026
thumbnail
Congress Presentation
The effect of long-term application of guideline-directed medical therapy on systolic blood pressure in hospitalized patients with heart failure with reduced ejection fraction
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources